Loading insider details...
Latest Form 4 (Sep 1, 2026): Disposition to Issuer of 13,300 CRNX shares, $1.13M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 1, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Disposition to Issuer | 13,300 | $1.13M |
| Jul 7, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale | 3,000 | $120.0K |
| Jun 22, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/Award | 5,925 | n/a |
| Mar 13, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale | 4,477 | $161.5K |
| Mar 10, 2026 | Viatris Inc (VTRS) | Exercise/Conversion | 23,660 | n/a |
| Jun 13, 2025 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/Award | 6,900 | n/a |
| Mar 10, 2025 | Viatris Inc (VTRS) | Grant/Award | 23,660 | n/a |
| Mar 6, 2025 | Viatris Inc (VTRS) | Exercise/Conversion | 21,267 | n/a |
| Jun 11, 2024 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/Award | 3,400 | n/a |
| Jun 4, 2024 | Viatris Inc (VTRS) | Grant/Award | 21,267 | n/a |